| Literature DB >> 18281929 |
Ioannis Papanastasiou1, Andrew Tsotinis, Nicolas Kolocouris, S Radhika Prathalingam, John M Kelly.
Abstract
To develop functionalized adamantanes for treating African trypanosomiasis, we report on the synthesis of new 1-alkyl-2-aminoadamantanes 1a- i, 1-alkyltricyclo[3.3.1.1 (3,7)]decan-2-guanylhydrazones 2a- g, and their congeneric thiosemicarbazones 3a, b. The potency of these compounds against Trypanosoma brucei was compared to that of amantadine and rimantadine and found to be substantially higher. The most active analogues, 1c, 1d, 2c, 2g, and 3b, illustrate the synergistic effect of the lipophilic character of the C1 side chain and the C2 functionality on trypanocidal activity.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18281929 PMCID: PMC2430315 DOI: 10.1021/jm7014292
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446